Johnson & Johnson Vaccine Validity In Austria

Austria has published a list of the types of vaccines that they recognize for travellers wishing to enter the country. The Johnson & Johnson vaccine is one of the vaccines that Austria accepts as proof of immunity. However, there are specific requirements for travellers who have received this vaccine, which include providing proof of a booster shot and ensuring that a certain number of days have passed since the vaccination.

Johnson & Johnson vaccine is accepted in Austria

Austria does accept the Johnson & Johnson vaccine. The country acknowledges proof of immunity for travellers inoculated with either an EMA-approved vaccine or a vaccine from the WHO's Emergency Use Listing. The Johnson & Johnson vaccine is one of the EMA-approved vaccines.

The Johnson & Johnson vaccine is also known as Janssen, and it is a single-shot vaccine. This means that for travel to Austria, you must show that you received the vaccine more than 21 but no more than 270 days before arrival. This is in contrast to double-shot vaccines, where the second injection must be no more than 270 days before arrival.

Austria's Official Travel Portal states:

> "The following vaccines (including mix-and-match vaccines) are recognized: BioNTech/Pfizer, AstraZeneca (Covishield), Johnson & Johnson, Moderna, Sinovac, and Sinopharm. (Please be aware that this only applies to entering the country. Sinovac/Sinopharm are not valid for entering hotels, restaurants etc. within Austria)."

Therefore, if you have had the Johnson & Johnson vaccine, you can enter Austria without needing to quarantine. However, you will still need to follow other entry requirements, such as providing a negative PCR test no older than 48 hours at the time of arrival.

It is a single-shot vaccine

Austria does accept the Johnson & Johnson COVID-19 vaccine for travellers entering the country. This vaccine is a single-shot vaccine, which means that it only requires one dose for a person to be considered fully vaccinated. This is in contrast to two-dose vaccines, such as those from Pfizer, AstraZeneca, and Moderna, which require two injections administered several weeks apart.

The Johnson & Johnson vaccine is the fourth vaccine to be endorsed for use in the European Union, following those from Pfizer, AstraZeneca, and Moderna. The European Medicines Agency (EMA) has approved the vaccine, stating that it is about 67% effective overall and that side effects are usually mild or moderate. This includes effects such as pain at the injection site, tiredness, muscle pain, headache, and nausea, which typically clear within a few days.

As a single-shot vaccine, the Johnson & Johnson vaccine offers several advantages. Firstly, it is easier to store and distribute since it only needs to be kept at fridge temperature. Secondly, it is more cost-effective, costing as little as $10 per dose. Finally, having a one-shot vaccine can help speed up vaccination campaigns, especially in poorer countries.

For travellers to Austria, the requirements for the Johnson & Johnson vaccine are as follows: proof of vaccination must be provided, and the vaccine must have been received more than 21 but no more than 270 days before arrival in the country. These requirements are in line with Austria's acceptance of other vaccines, such as those from BioNTech/Pfizer, AstraZeneca, and Moderna.

It is cheaper than most vaccines

Austria does accept the Johnson & Johnson vaccine as proof of immunity for travellers entering the country. The Johnson & Johnson vaccine is also cheaper than most vaccines.

The Johnson & Johnson vaccine is a single-shot vaccine, which is more affordable than most other vaccines, which require two doses. In a deal with the US government, Johnson & Johnson priced its vaccine at about $10 per dose, much lower than the Pfizer ($19 per dose) and Moderna ($25 to $37 per dose) vaccines. The UK has ordered 30 million doses of the vaccine, pending approval by the MHRA, with the option of millions more. Johnson & Johnson has also stated that it wants to allocate up to 500 million vaccine doses to lower-income countries.

The Johnson & Johnson vaccine is delivered by a harmless virus called Adenovirus 26, a human virus uncommon in nature, so most people have not built immunity to it. This vaccine only needs to be kept at fridge temperature, making its storage, distribution, and handling much easier.

The Johnson & Johnson vaccine is 85% effective in preventing the most serious coronavirus symptoms, according to data from mass trials. The vaccine also worked across multiple variants of the coronavirus, including the South African variant. The injection's efficacy rate in preventing the most severe cases will potentially protect hundreds of millions of people from serious and fatal outcomes of COVID-19.

It works across multiple variants of coronavirus

Austria does accept the Johnson & Johnson vaccine as proof of immunity. The country acknowledges proof of immunity if the visitor has been inoculated with either an EMA-approved vaccine or a vaccine from the WHO’s Emergency Use Listing.

The Johnson & Johnson vaccine has been shown to work across multiple variants of the coronavirus. In a clinical trial involving 43,783 people, the level of protection against moderate to severe Covid-19 infection was found to be 72% in the United States, 66% in Latin America, and 57% in South Africa, where a mutant variant of the virus was dominant. The overall efficacy from these trials was 67%.

The vaccine has been approved for use in the UK, with the Medicines and Healthcare Products Regulatory Agency (MHRA) confirming its safety. The vaccine was shown to be 67% effective overall in preventing moderate to severe Covid-19, with studies suggesting it also offers complete protection from hospitalisation and death. The MHRA did, however, express that there is a “possible link” between the vaccine and very rare blood clots, but that the benefits of the vaccine outweigh the risks of side effects.

It is easier to store than other vaccines

Austria accepts the Johnson & Johnson COVID-19 vaccine as proof of immunity for travellers entering the country. The Johnson & Johnson vaccine is a single-dose vaccine, which is easier to store than other vaccines.

The Johnson & Johnson vaccine is a viral vector vaccine, whereas the Pfizer and Moderna vaccines are mRNA vaccines. The Johnson & Johnson vaccine uses a viral vector technology to instruct our cells to make a spike protein, which is found on the surface of the SARS-CoV-2 virus. This spike protein triggers an immune response in our body, which produces antibodies to fight the virus. The benefit of this vaccine is that it does not use the SARS-CoV-2 virus and instead uses a harmless vector, so it is impossible to get COVID-19 from the vaccine.

The Johnson & Johnson vaccine only requires one shot, unlike the Pfizer and Moderna vaccines, which require two shots given several weeks apart. This makes the Johnson & Johnson vaccine easier to store and distribute, as each person only needs one shot. This is especially beneficial for vaccine supply and access, as well as for rural areas or communities without access to ultra-cold pharmacy-grade freezers. The Johnson & Johnson vaccine can be stored for up to three months in a regular refrigerator, making it easy to ship and store anywhere in the world.

In addition to being easier to store, the Johnson & Johnson vaccine has been shown to be highly effective in preventing serious illness and death from COVID-19. In clinical trials, not a single participant who received the vaccine and later contracted COVID-19 became sick enough to require hospitalisation. The vaccine was shown to be 72% effective in preventing moderate COVID-19 infections in the United States, and 85% effective in preventing severe illness and hospitalisation across all trials. While the Pfizer and Moderna vaccines were shown to be slightly more effective, with a 95% and 94% efficacy rate respectively, they were also studied prior to the emergence of new COVID-19 variants, which may explain the discrepancy.

The ease of storage and distribution, as well as the high efficacy of the Johnson & Johnson vaccine, make it a valuable tool in the fight against COVID-19, especially in rural or hard-to-reach communities.

Frequently asked questions